Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Neoplasms × Oncolytic Virotherapy × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms, Neuroepithelial 1 Neoplasms, Nerve Tissue 1 Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Disease 1 CRC 1 Brain Neoplasms 1

Interventions

Gemcitabine 294 Fluorouracil 81 Oxaliplatin 80 130-nm albumin-bound paclitaxel 67 Capecitabine 60 Leucovorin 55 Albumin-Bound Paclitaxel 53 Radiotherapy 51 Irinotecan 44 Taxes 38 Cisplatin 36 Erlotinib Hydrochloride 34 Radiosurgery 32 pembrolizumab 29 Docetaxel 27 S 1 (combination) 26 Bevacizumab 23 folfirinox 22 Nivolumab 21 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 Cetuximab 17 Radiation 16 irinotecan sucrosofate 15 Drug Therapy 15 Surgical Procedures, Operative 14 Specimen Handling 11 Paclitaxel 11 Biopsy 11 durvalumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06196671 2025-08-07

PTCA199-8

Fudan University

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡